California-based microbiome company Evolve BioSystems has completed a $20 million Series B financing to fund the commercialization of its initial products.
from NutraIngredients RSS http://ift.tt/2rp4Egw
via IFTTT
information on Dietary Supplements
California-based microbiome company Evolve BioSystems has completed a $20 million Series B financing to fund the commercialization of its initial products.